Smad8/9 Is Regulated Through the BMP Pathway

Journal of Cellular Biochemistry

Volumn , Issue , 2016, Pages 1788-1796

  Katakawa, Yuko ^a   Funaba, Masayuki ^b   Murakami, Masaru ^a  

^a AZABU UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

BMP; SMAD8 9; TRANSCRIPTION

Indexed keywords

BETA ACTIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; MESSENGER RNA; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; SMAD9 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DNA SEQUENCE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84975076440     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25478     Document Type: Article

References (32)

1. Cheng KH, Ponte JF, Thiagalingam S. 2004. Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display. Cancer Res 64:1639–1646.
2. Derynck R, Piek E, Schneider RA, Choy L, Alliston T. 2008. TGF-b family signaling in mesenchymal differentiation. In: Derynck R, Miyazono K, editors. The TGF-b family. New York: Cold Spring Harbor Laboratory Press. pp 613–665.
3. Duan X, Liang YY, Feng XH, Lin X. 2006. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. J Biol Chem 281:36526–36532.
4. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. Smurf1 interacts with transforming growth factor-b type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276:12477–12480.
5. Furutani Y, Umemoto T, Murakami M, Matsui T, Funaba M. 2011. Role of endogenous TGF-β family in myogenic differentiation of C2C12 cells. J Cell Biochem 112:614–624.
6. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Jr., Wrana JL, Falb D. 1997. The MAD-related protein Smad7 associates with the TGFb receptor and functions as an antagonist of TGFb signaling. Cell 89:1165–1173.
7. Herrera B, van Dinther M, Ten Dijke P. 2009. Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation. Cancer Res 69:9254–2962.
8. Hester M, Thompson JC, Mills J, Liu Y, El-Hodiri HM, Weinstein M. 2005. Smad1 and Smad8 function similarly in mammalian central nervous system development. Mol Cell Biol 25:4683–4692.
9. Ishisaki A, Yamato K, Nakao A, Nonaka K, Ohguchi M, Ten Dijke P. 1998. Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells. J Biol Chem 273:24293–24296.
10. Kawai S, Faucheu C, Gallea S, Spinella-Jaegle S, Atfi A, Baron R, Roman SR. 2000. Mouse smad8 phosphorylation downstream of BMP receptors ALK-2, ALK-3, and ALK-6 induces its association with Smad4 and transcriptional activity. Biochem Biophys Res Commun 271:682–687.
11. Knockaert M, Sapkota G, Alarcón C, Massagué J, Brivanlou AH. 2006. Unique players in the BMP pathway: Small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc Natl Acad Sci USA 103:11940–11945.
12. Kusanagi K, Inoue H, Ishidou Y, Mishima HK, Kawabata M, Miyazono K. 2000. Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell 11:555–565.
13. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, Shi Y, Chen YG, Meng A, Feng XH. 2006. PPM1A functions as a Smad phosphatase to terminate TGFb signaling. Cell 125:915–928.
14. López-Rovira T, Chalaux E, Massagué J, Rosa JL, Ventura F. 2002. Direct binding of Smad1 and Smad4 to two distinct motifs mediates bone morphogenetic protein- specifictranscriptional activation of Id1 gene. J Biol Chem 277:3176–3185.
15. Massagué J. 2012. TGFβ signalling in context. Nat Rev Mol Cell Biol 13:616–630.
16. Messenger AG. 1984. The culture of dermal papilla cells from human hair follicles. Br J Dermatol 110:685–689.
17. Miyazono K, Kamiya Y, Morikawa M. 2010. Bone morphogenetic protein receptors and signal transduction. J Biochem 147:35–51.
18. Murakami M, Kawachi H, Ogawa K, Nishino Y, Funaba M. 2009. Receptor expression modulates the specificity of transforming growth factor-β signaling pathways. Genes Cells 14:469–482.
19. Murakami M, Ohi M, Ishikawa S, Shirai M, Horiguchi H, Nishino Y, Funaba M. 2015. Adaptive expression of uncoupling protein 1 in the carp liver and kidney in response to changes in ambient temperature. Comp Biochem Physiol A Mol Integr Physiol 185:142–149.
20. Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. 2003. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell 14:2809–2817.
21. Nakahiro T, Kurooka H, Mori K, Sano K, Yokota Y. 2010. Identification of BMP-responsive elements in the mouse Id2 gene. Biochem Biophys Res Commun 399:416–421.
22. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, Ten Dijke P. 1997. Identification of Smad7, a TGFb-inducible antagonist of TGF-b signalling. Nature 389:631–635.
23. Nishita M, Ueno N, Shibuya H. 1999. Smad8B, a Smad8 splice variant lacking the SSXS site that inhibits Smad8-mediated signaling. Genes Cells 4:583–591.
24. Poncelet AC, de Caestecker MP, Schnaper HW. 1999. The transforming growth factor-b /SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 56:1354–1365.
25. Sakaki-Yumoto M, Katsuno Y, Derynck R. 2013. TGF-β family signaling in stem cells. Biochim Biophys Acta 1830:2280–2296.
26. Takase M, Imamura T, Sampath TK, Takeda K, Ichijo H, Miyazono K, Kawabata M. 1998. Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun 244:26–29.
27. Truksa J, Lee P, Beutler E. 2009. Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood 113:688–695.
28. Tsukamoto S, Mizuta T, Fujimoto M, Ohte S, Osawa K, Miyamoto A, Yoneyama K, Murata E, Machiya A, Jimi E, Kokabu S, Katagiri T. 2014. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling. Sci Rep 4:7596.
29. Wei CY, Wang HP, Zhu ZY, Sun YH. 2014. Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5. J Biol Chem 289:6604–6618.
30. Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, Gregorevic P. 2011. TGF-b regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem 286:13805–13814.
31. Yanagisawa K, Osada H, Masuda A, Kondo M, Saito T, Yatabe Y, Takagi K, Takahashi T, Takahashi T. 1998. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-b in human normal lung epithelial cells. Oncogene 17:1743–1747.
32. Yu PB, Deng DY, Lai CS, Hong CC, Cuny GD, Bouxsein ML, Hong DW, McManus PM, Katagiri T, Sachidanandan C, Kamiya N, Fukuda T, Mishina Y, Peterson RT, Bloch KD. 2008. BMP type I receptor inhibition reduces heterotopic ossification. Nat Med 14:1363–1369.